A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee.

J Carmichael; B M Cantwell; K A Mannix; D Veale; H L Elford; R Blackie; D J Kerr; S B Kaye; A L Harris

doi:10.1038/bjc.1990.98

A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee.

Identifier:nobleid.org/w1/20260515/CB4FD08A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CB4FD08A.svg?ark=w1%2F20260515%2FCB4FD08A)](https://nobleid.org/work/w1/20260515/CB4FD08A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee.

Identifier:nobleid.org/w1/20260515/CB4FD08A

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CB4FD08A.svg?ark=w1%2F20260515%2FCB4FD08A)](https://nobleid.org/work/w1/20260515/CB4FD08A)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work